Creative Biolabs-Immuno-oncology

PharmaOnco™ CHO-Tg(Human BCMA//Gluc) Stable Cell Line, Single Clone (CAT#: ITS-0822-HMM104)

DatasheetDatasheet
Short Description
Creative Biolabs offers CHO-Tg(Human BCMA//Gluc) stable cell line which the BCMA gene stably expressed in CHO cells.
Description
The CHO-Tg(Human BCMA//Gluc) stable cell line is a genetically engineered Chinese Hamster Ovary (CHO) cell line that has been transfected with a construct containing the gene for the human B-cell maturation antigen (BCMA) fused to the gene for Gaussia luciferase (Gluc). This stable cell line allows for the production of BCMA protein along with the secretion of Gluc, which can be used as a reporter gene for monitoring protein expression and secretion levels. This cell line is commonly used in research and drug development studies related to BCMA-targeted therapies for multiple myeloma and other B-cell malignancies.
Features
Consistent gene expression;
Reliability and reproducibility;
Applications
Functional assay
Protein Target
BCMA
Species
Human
Parental Cell Line
CHO
Gene
GenBank accession #NM_001192
Background
The BCMA (B cell maturation antigen) gene is located on chromosome 16q23 and encodes a cell surface protein that is a member of the tumor necrosis factor receptor superfamily. BCMA is primarily expressed on the surface of plasma cells and activated memory B cells, and it plays a crucial role in the survival and function of these cells. BCMA interacts with its ligands BAFF (B cell activating factor) and APRIL (a proliferation-inducing ligand) to promote the survival and differentiation of plasma cells, as well as regulate the immune response. Dysregulation of BCMA signaling has been associated with various autoimmune diseases and cancers, making it a potential therapeutic target for these conditions. Mutations in the BCMA gene have been linked to multiple myeloma, a type of cancer that affects plasma cells, as well as other B cell-related disorders. Targeting BCMA with monoclonal antibodies and chimeric antigen receptor (CAR) T-cell therapies has shown promising results in the treatment of multiple myeloma and other B cell malignancies.
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving